Your browser doesn't support javascript.
loading
Growth dynamics in naturally progressing chronic lymphocytic leukaemia.
Gruber, Michaela; Bozic, Ivana; Leshchiner, Ignaty; Livitz, Dimitri; Stevenson, Kristen; Rassenti, Laura; Rosebrock, Daniel; Taylor-Weiner, Amaro; Olive, Oriol; Goyetche, Reaha; Fernandes, Stacey M; Sun, Jing; Stewart, Chip; Wong, Alicia; Cibulskis, Carrie; Zhang, Wandi; Reiter, Johannes G; Gerold, Jeffrey M; Gribben, John G; Rai, Kanti R; Keating, Michael J; Brown, Jennifer R; Neuberg, Donna; Kipps, Thomas J; Nowak, Martin A; Getz, Gad; Wu, Catherine J.
Afiliación
  • Gruber M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Bozic I; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Leshchiner I; Department of Internal Medicine I, Division of Haematology and Haemostaseology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Livitz D; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
  • Stevenson K; Department of Applied Mathematics, University of Washington, Seattle, WA, USA.
  • Rassenti L; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Rosebrock D; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Taylor-Weiner A; Department of Biostatistics and Computational Biology, Dana Farber Cancer Institute, Boston, MA, USA.
  • Olive O; Department of Medicine, University of California at San Diego Moores Cancer Center, La Jolla, CA, USA.
  • Goyetche R; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Fernandes SM; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Sun J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Stewart C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Wong A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Cibulskis C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Zhang W; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Reiter JG; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Gerold JM; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Gribben JG; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Rai KR; Program for Evolutionary Dynamics, Harvard University, Cambridge, MA, USA.
  • Keating MJ; Program for Evolutionary Dynamics, Harvard University, Cambridge, MA, USA.
  • Brown JR; Barts Cancer Institute, Queen Mary, University of London, London, UK.
  • Neuberg D; Hofstra North Shore-LIJ School of Medicine, Lake Success, NY, USA.
  • Kipps TJ; Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USA.
  • Nowak MA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Getz G; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
  • Wu CJ; Harvard Medical School, Boston, MA, USA.
Nature ; 570(7762): 474-479, 2019 06.
Article en En | MEDLINE | ID: mdl-31142838

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Progresión de la Enfermedad / Evolución Molecular Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: Nature Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Progresión de la Enfermedad / Evolución Molecular Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: Nature Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos